These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

165 related items for PubMed ID: 9067339

  • 1. In vitro characterization of botulinum toxin types A, C and D action on human tissues: combined electrophysiologic, pharmacologic and molecular biologic approaches.
    Coffield JA, Bakry N, Zhang RD, Carlson J, Gomella LG, Simpson LL.
    J Pharmacol Exp Ther; 1997 Mar; 280(3):1489-98. PubMed ID: 9067339
    [Abstract] [Full Text] [Related]

  • 2. Lectins from Triticum vulgaris and Limax flavus are universal antagonists of botulinum neurotoxin and tetanus toxin.
    Bakry N, Kamata Y, Simpson LL.
    J Pharmacol Exp Ther; 1991 Sep; 258(3):830-6. PubMed ID: 1653841
    [Abstract] [Full Text] [Related]

  • 3. Characterization of a vertebrate neuromuscular junction that demonstrates selective resistance to botulinum toxin.
    Coffield JA, Bakry NM, Maksymowych AB, Simpson LL.
    J Pharmacol Exp Ther; 1999 Jun; 289(3):1509-16. PubMed ID: 10336546
    [Abstract] [Full Text] [Related]

  • 4. Action of botulinum A toxin and tetanus toxin on synaptic transmission.
    Dreyer F, Becker C, Bigalke H, Funk J, Penner R, Rosenberg F, Ziegler M.
    J Physiol (Paris); 1984 Jun; 79(4):252-8. PubMed ID: 6152293
    [Abstract] [Full Text] [Related]

  • 5. [Structure and function of botulinum toxin].
    Fujii N.
    Hokkaido Igaku Zasshi; 1995 Jan; 70(1):19-28. PubMed ID: 7744367
    [Abstract] [Full Text] [Related]

  • 6. Chelation of zinc antagonizes the neuromuscular blocking properties of the seven serotypes of botulinum neurotoxin as well as tetanus toxin.
    Simpson LL, Coffield JA, Bakry N.
    J Pharmacol Exp Ther; 1993 Nov; 267(2):720-7. PubMed ID: 8246147
    [Abstract] [Full Text] [Related]

  • 7. The action of batulinum toxin at the neuromuscular junction.
    Sellin LC.
    Med Biol; 1981 Feb; 59(1):11-20. PubMed ID: 6115105
    [Abstract] [Full Text] [Related]

  • 8. The binding fragment from tetanus toxin antagonizes the neuromuscular blocking actions of botulinum toxin.
    Simpson LL.
    J Pharmacol Exp Ther; 1984 Apr; 229(1):182-7. PubMed ID: 6707933
    [Abstract] [Full Text] [Related]

  • 9. Different effects of types A and B botulinum toxin on transmitter release at the rat neuromuscular junction.
    Sellin LC, Thesleff S, Dasgupta BR.
    Acta Physiol Scand; 1983 Apr; 119(2):127-33. PubMed ID: 6140815
    [Abstract] [Full Text] [Related]

  • 10. [Mode of action and effects of botulinum neurotoxin A].
    Périé S, Lacau St-Guily J.
    Ann Otolaryngol Chir Cervicofac; 1996 Apr; 113(2):73-8. PubMed ID: 8999747
    [Abstract] [Full Text] [Related]

  • 11. Cleavage of SNAP-25 by botulinum toxin type A requires receptor-mediated endocytosis, pH-dependent translocation, and zinc.
    Kalandakanond S, Coffield JA.
    J Pharmacol Exp Ther; 2001 Mar; 296(3):980-6. PubMed ID: 11181932
    [Abstract] [Full Text] [Related]

  • 12. In vitro microelectrode study of neuromuscular transmission in a case of botulism.
    Maselli RA, Burnett ME, Tonsgard JH.
    Muscle Nerve; 1992 Mar; 15(3):273-6. PubMed ID: 1313544
    [Abstract] [Full Text] [Related]

  • 13. Botulinum neurotoxin serotype D is poorly effective in humans: an in vivo electrophysiological study.
    Eleopra R, Montecucco C, Devigili G, Lettieri C, Rinaldo S, Verriello L, Pirazzini M, Caccin P, Rossetto O.
    Clin Neurophysiol; 2013 May; 124(5):999-1004. PubMed ID: 23245668
    [Abstract] [Full Text] [Related]

  • 14. Different types of botulinum toxin in humans.
    Eleopra R, Tugnoli V, Quatrale R, Rossetto O, Montecucco C.
    Mov Disord; 2004 Mar; 19 Suppl 8():S53-9. PubMed ID: 15027055
    [Abstract] [Full Text] [Related]

  • 15. A capillary electrophoresis method to assay catalytic activity of botulinum neurotoxin serotypes: implications for substrate specificity.
    Purcell AL, Hoard-Fruchey HM.
    Anal Biochem; 2007 Jul 15; 366(2):207-17. PubMed ID: 17548044
    [Abstract] [Full Text] [Related]

  • 16. Botulinum neurotoxin type E: studies on mechanism of action and on structure-activity relationships.
    Simpson LL, Dasgupta BR.
    J Pharmacol Exp Ther; 1983 Jan 15; 224(1):135-40. PubMed ID: 6294275
    [Abstract] [Full Text] [Related]

  • 17. Use of pharmacologic antagonists to deduce commonalities of biologic activity among clostridial neurotoxins.
    Simpson LL.
    J Pharmacol Exp Ther; 1988 Jun 15; 245(3):867-72. PubMed ID: 2455038
    [Abstract] [Full Text] [Related]

  • 18. Comparison of the effects of botulinum neurotoxin types A and E at the rat neuromuscular junction.
    Sellin LC, Kauffman JA, Dasgupta BR.
    Med Biol; 1983 Apr 15; 61(2):120-5. PubMed ID: 6308364
    [Abstract] [Full Text] [Related]

  • 19. Cleavage of intracellular substrates of botulinum toxins A, C, and D in a mammalian target tissue.
    Kalandakanond S, Coffield JA.
    J Pharmacol Exp Ther; 2001 Mar 15; 296(3):749-55. PubMed ID: 11181902
    [Abstract] [Full Text] [Related]

  • 20. Early structural changes in the motor nerve terminals of rat skeletal muscle after local injection of botulinum toxin [proceedings].
    Duxson MJ, Stolkin C.
    J Physiol; 1979 Nov 15; 296():12P. PubMed ID: 529073
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.